azathioprine has been researched along with Absence of Brain, Congenital in 1 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
King, LR | 1 |
Gerbie, AG | 1 |
Idriss, FS | 1 |
Swenson, O | 1 |
Siegel, A | 1 |
DelGreco, F | 1 |
Grayhack, J | 1 |
Gross, M | 1 |
Gonzales, E | 1 |
Stolpe, Y | 1 |
1 other study available for azathioprine and Absence of Brain, Congenital
Article | Year |
---|---|
Human renal transplantation with kidney grafts from the newborn.
Topics: Adolescent; Anencephaly; Azathioprine; Cadaver; Child; Female; gamma-Globulins; Graft Rejection; Hum | 1971 |